RPRX
$57.16-0.82%
as of close, Oct 2, 2026
☾ AH $57.16 -0.82%
Royalty Pharma plcStock · Health CareNasdaq Composite 0.05%Russell 1000 0.03%Russell 3000 0.03%MSCI World 0.02%MSCI ACWI 0.02%
Royalty Pharma plc monthly returns
Royalty Pharma plc has averaged 0.55% per month, positive in 53% of months. Month-by-month returns for Royalty Pharma plc (RPRX) below, through October 2, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+0.5%
70 months
Best month
+23.8%
Jan 2025
Worst month
-10.1%
Dec 2022
Positive months
53%
of all months
Royalty Pharma plc monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -2.1% | |
| Sep 2026 | -5.0% | |
| Aug 2026 | +5.5% | |
| Jul 2026 | +4.2% | |
| Jun 2026 | +0.6% | |
| May 2026 | +11.8% | |
| Apr 2026 | +4.4% | |
| Mar 2026 | +3.8% | |
| Feb 2026 | +11.4% | |
| Jan 2026 | +7.9% | |
| Dec 2025 | -3.4% | |
| Nov 2025 | +7.2% | |
| Oct 2025 | +6.4% | |
| Sep 2025 | -1.9% | |
| Aug 2025 | -1.6% | |
| Jul 2025 | +2.1% | |
| Jun 2025 | +9.6% | |
| May 2025 | +0.9% | |
| Apr 2025 | +5.4% | |
| Mar 2025 | -7.5% | |
| Feb 2025 | +7.2% | |
| Jan 2025 | +23.8% | |
| Dec 2024 | -4.3% | |
| Nov 2024 | -0.4% | |
| Oct 2024 | -4.6% | |
| Sep 2024 | -2.5% | |
| Aug 2024 | +3.8% | |
| Jul 2024 | +6.8% | |
| Jun 2024 | -3.8% | |
| May 2024 | -0.3% | |
| Apr 2024 | -8.8% | |
| Mar 2024 | +0.1% | |
| Feb 2024 | +7.6% | |
| Jan 2024 | +1.1% | |
| Dec 2023 | +3.8% | |
| Nov 2023 | +1.5% | |
| Oct 2023 | -1.0% | |
| Sep 2023 | -9.0% | |
| Aug 2023 | -4.3% | |
| Jul 2023 | +2.1% | |
| Jun 2023 | -6.1% | |
| May 2023 | -6.3% | |
| Apr 2023 | -2.4% | |
| Mar 2023 | +0.5% | |
| Feb 2023 | -8.0% | |
| Jan 2023 | -0.8% | |
| Dec 2022 | -10.1% | |
| Nov 2022 | +4.4% | |
| Oct 2022 | +5.3% | |
| Sep 2022 | -3.9% | |
| Aug 2022 | -3.5% | |
| Jul 2022 | +3.4% | |
| Jun 2022 | +2.2% | |
| May 2022 | -2.9% | |
| Apr 2022 | +9.3% | |
| Mar 2022 | -0.8% | |
| Feb 2022 | -1.4% | |
| Jan 2022 | +0.4% | |
| Dec 2021 | +0.2% | |
| Nov 2021 | +1.0% | |
| Oct 2021 | +9.4% | |
| Sep 2021 | -6.5% | |
| Aug 2021 | +1.6% | |
| Jul 2021 | -6.8% | |
| Jun 2021 | +2.2% | |
| May 2021 | -8.4% | |
| Apr 2021 | +0.9% | |
| Mar 2021 | -6.3% | |
| Feb 2021 | -0.6% | |
| Jan 2021 | -6.1% | |
| Dec 2020 | +17.5% | |
| Nov 2020 | +16.5% | |
| Oct 2020 | -12.8% | |
| Sep 2020 | +2.1% | |
| Aug 2020 | -3.9% | |
| Jul 2020 | -11.3% |
Monthly total return (since Nov 2021)#
-20%-10%0%10%20%
Nov 2021+1.0%
Dec 2021+0.2%
Jan 2022+0.4%2022
Feb 2022-1.4%
Mar 2022-0.76%
Apr 2022+9.3%
May 2022-2.9%
Jun 2022+2.2%
Jul 2022+3.4%
Aug 2022-3.5%
Sep 2022-3.9%
Oct 2022+5.3%
Nov 2022+4.4%
Dec 2022-10%
Jan 2023-0.84%2023
Feb 2023-8.0%
Mar 2023+0.5%
Apr 2023-2.4%
May 2023-6.3%
Jun 2023-6.1%
Jul 2023+2.1%
Aug 2023-4.3%
Sep 2023-9.0%
Oct 2023-0.99%
Nov 2023+1.5%
Dec 2023+3.8%
Jan 2024+1.1%2024
Feb 2024+7.6%
Mar 2024+0.1%
Apr 2024-8.8%
May 2024-0.3%
Jun 2024-3.8%
Jul 2024+6.8%
Aug 2024+3.8%
Sep 2024-2.5%
Oct 2024-4.6%
Nov 2024-0.44%
Dec 2024-4.3%
Jan 2025+24%2025
Feb 2025+7.2%
Mar 2025-7.5%
Apr 2025+5.4%
May 2025+0.85%
Jun 2025+9.6%
Jul 2025+2.1%
Aug 2025-1.6%
Sep 2025-1.9%
Oct 2025+6.4%
Nov 2025+7.2%
Dec 2025-3.4%
Jan 2026+7.9%2026
Feb 2026+11%
Mar 2026+3.8%
Apr 2026+4.4%
May 2026+12%
Jun 2026+0.56%
Jul 2026+4.2%
Aug 2026+5.5%
Sep 2026-5.0%
Oct 2026-2.1%
Methodology#
Monthly returns are total returns (dividends reinvested), computed from RPRX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Royalty Pharma plc's average monthly return?
- Royalty Pharma plc (RPRX) has averaged about 0.55% per month, positive in roughly 53% of months. The best month was Jan 2025 (+23.8%) and the worst was Dec 2022 (-10.1%).
More on Royalty Pharma plc
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100